Search Results for "Dr David Tan Desire System"

21:24 EDT 4th October 2015 | BioPortfolio

Matching Channels

Matching News

FDA approves first treatment for sexual desire disorder

The U.S. Food and Drug Administration today approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Prior to Addyi’s approval, th...

FDA approves Addyi, Sprout’s ‘female Viagra’

David SalazarThe Food and Drug Administration handed down its anticipated approval of Sprout Pharmaceuticals’ Addyi, a treatment for women with generalized hypoactive sexual desire disorder.&nbs...

MULTIMEDIA RELEASE -- Lumenis' LightSheer(R) DESIRE(TM) Laser Hair Removal System Receives the Core77 Design Award

YOKNEAM, Israel, July 30, 2015 (GLOBE NEWSWIRE) -- Lumenis Ltd. (NASDAQ:LMNS), the world's largest energy-based medical device company for aesthetic, surgical and ophthalmology applications, today an...

FDA Embraces Sex Pill For Women; Restrictions Apply

Specifically, Addyi is indicated as a once-daily treatment for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes...

Women's Sexual Function Depends Most on Desire, Arousal

For middle-aged women, sexual function and satisfaction may depend most on desire and arousal, a small study suggests. Reuters Health Information

Flibanserin for Treating Low Sexual Desire in Women

Low sexual desire (libido) is a common type of sexual dysfunction in women and can be challenging to treat.

Dexcom gets FDA approval for G5 Mobile CGM system

David SalazarGlucose monitoring device company Dexcom announced Tuesday that the Food and Drug Administration had approved its G5 Mobile Continuous Glucose Monitoring System. read more

FDA OKs first pill for boosting sexual desire in women, but it comes with safety restrictions

The Food and Drug Administration has approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to replicate the blockbus...

Matching PubMed Articles

On Becoming a Pharmacologist: Channeling David Triggle.

This Festschrift contribution summarizes the perspectives of two of David Triggle's graduate students. Both share somewhat parallel scientific and career paths-i.e., enrolling in the Biochemical Pharm...

For lack of wanting: Discourses of desire in Ukrainian opiate substitution therapy programs.

Available treatments for addiction and substance abuse in Ukraine have been shaped by the economic, political, and social shifts that have followed the country's independence. The introduction of meth...

To be or not to be in sexual desire: the androgen dilemma.

The androgen milieu and sexual desire in women seem to be tightly linked because they both decline with age. However, we are still missing a cut-off plasma level for androgens (total testosterone, fre...

On Integrating the Components of Self-Control.

As the science of self-control matures, the organization and integration of its key concepts becomes increasingly important. In response, we identified seven major components or "nodes" in current the...

Smoking and Desire to Quit Smoking Behavior in a Sample of Turkish Adolescents.

The age of starting the habit of smoking, one of the top causes of many illnesses, is usually in the period of adolescence. This study was conducted to determine students' smoking status and to explor...

Search Whole site using Google


Advertisement Advertisement